Top Three Players Account for more than 40% of the Global IVD Market

Innovations and technical advancements of their IVD products, along with growth in diversified clinical segments across geographies are the key reasons for this leadership, says RNCOS.

NOIDA, India (prHWY.com) March 22, 2013 - As per the new research report by RNCOS, "In-Vitro Diagnostics Market Analysis to 2017", in 2012, just three players accounted for more than 40% share in the global IVD market. Beside others, the common reasons behind this finding include their good spread into all major clinical segments along with leadership in premium markets of molecular diagnostics and POCT. Moreover, they have a widespread reach in all major IVD markets, with a strong foothold in emerging economies.

Other key attributes along with each company's vital details like the historical and current financial analysis, assessment of its revenue generation from various clinical segments of IVD and a prudent strength and weakness analysis have been provided in the study. Further, such valuation has been done for all the major 14 market players, that together account for around 80% of the global IVD industry. This will help the reader to gain a deeper insight into the current competitive landscape and position its company accordingly.

Besides, key IVD markets across geographies have been analyzed will give the reader a detailed understanding of the market dynamics. Each region's current and future outlook to 2017 has also been discussed. Further, each market has been broken down into eight distinct clinical segmentations and their current and future outlook to 2017 has been assessed to provide a thorough opportunity assessment for players.

The report provides a thorough research and rational analysis of the current status and expected position of the global IVD market. The analysis of the emerging sectors and key players in the market provides a holistic view to the reader. Explaining some of the constraints faced by the industry, the study also covers the emerging trends which would have a positive impact on the market growth. Overall, the report contains key actionable insights that will help the reader to gain a deeper knowledge of the industry, identify key opportunities and design suitable business strategies.

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM472.htm

Some of our Related Reports are:

- US Telelaparoscopy Opportunity Analysis (http://www.rncos.com/Report/IM469.htm)
- US Proton Therapy Market Analysis to 2017 (http://www.rncos.com/Report/IM465.htm)
- US Personalized Cancer Genome Sequencing Market (http://www.rncos.com/Report/IM453.htm)
- Brazil Healthcare - New Opportunities for Growth (http://www.rncos.com/Report/IM451.htm)
- US Non-Invasive Prenatal Diagnostics - Market Insight (http://www.rncos.com/Report/IM450.htm)

Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm

About RNCOS

RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals analyze the industry and its various components, with a comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the intending consultants in meeting their objectives in a cost-effective and timely manner.

###

Tag Words: immunochemistry market

Categories: Health

Press Release Contact
B-129, Sector 6 Noida - 201301
91-120-4224-700
91-120-4224-707

Link To This Press Release:

URL HTML Code